Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease
- Pasma, A. (Annelieke)
- Schenk, C.V. (Charlotte V.)
- Timman, R. (Reinier)
- Busschbach, J.J. (Jan) van
- Bemt, B.J.F. (Bart) van den
- Molenaar, E.T.H. (E. T H)
- van der Laan, W.H. (Willemijn H.)
- Schrauwen, S. (Saskia)
- Spijker, A. (Adriaan) van 't
- Hazes, J.M.W. (Mieke)
Publication date
October 2015
DOI Publisher
Springer Science and Business Media LLC ISSN
1478-6354 Citation count (estimate)
16Abstract
Introduction: Non-adherence to disease-modifying antirheumatic drugs (DMARDs) hampers the targets of rheumatoid arthritis (RA) treatment, obtaining low disease activity and decreasing radiological progression. This study investigates if, and to what extent, non-adherence to treatment would lead to a higher 28-
Add to ORKG